Dysregulation of microRNAs (miRNAs) can contribute to tumorigenesis in cancers. In this study, we found that miR-429 was downregulated in cervical cancer (CC) tissues and suppressed cell viability and proliferation while promoting apoptosis in CC cells. IKKb was a novel target gene of miR-429 and ectopic expression of IKKb abrogated the phenotypes induced by miR-429. When IKKb was downregulated by miR-429, nuclear factor jB (NF-jB) pathway activation, interleukin-6 (IL-6), and interferon-b (IFN-b) production were decreased in CC cells. These findings indicate that miR-429 is involved in regulation of the NF-jB pathway by targeting IKKb and functions as a tumor suppressor in cervical carcinogenesis.
Cervical cancer (CC) is the fourth most common cancer in women globally and the second most common cancer in developing areas. Moreover, CC is also the third most common cause of cancer-related death in developing countries [1] . Such high mortality rates are ascribed to disease recurrence despite cervical resection as well as ineffective treatment options for advanced disease. Although infection with high-risk types of human papillomavirus (HPV) has been considered as the major cause of CC, genetic and epigenetic alterations of host cellular genes also play a crucial role in cervical malignant transformation [2] . Therefore, an understanding of the mechanisms underlying the development of CC is very important for the identification of new potential biomarkers and therapy approaches.
Recent findings indicate that numerous microRNAs (miRNAs) participate in the development and progression of CC [3] [4] [5] . miRNAs, typically 18-25 nucleotides in length, are small single-stranded noncoding RNAs. They serve as important post-transcriptional regulators of gene expression. Evidence has shown that miRNAs are involved in various physiological processes including developmental timing, cellular proliferation, differentiation, metabolism, apoptosis, and tumorigenesis [6] [7] [8] [9] [10] [11] [12] [13] . Specifically, miR-429 has been reported to be deregulated and to play a tumor-suppressive role in some types of cancer. For example, miR-429 is downregulated in gastric cancer (GC), resulting in enhanced Bcl-2 protein translation, which subsequently allows GC cells to survive chemotherapy [14] . Meanwhile, miR-429 inhibits the initiation of epithelial-mesenchymal transition, migration, and invasion by targeting the transcription factor Onecut2 in colorectal carcinoma [15] . However, the role of miR-429 in CC remains unclear.
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Nuclear factor jB (NF-jB) is a sequence-specific transcription factor that plays an important role in tumorigenesis [16] . NF-jB belongs to the Rel family, which has five members: NF-jB1 (p50), NF-jB2 (p52), RelA (p65), RelB, c-Rel (Rel). Generally, p50/ p65 is the predominant inducible form of NF-jB in most cells [17, 18] . In resting, nonstimulated cells, NFjB dimers are cytoplasmic and exhibit no activity. They are activated in response to microbial and viral infections and proinflammatory cytokines, all of which activate the IjB kinase (IKK) complex [19] . The IKK complex phosphorylates and degrades inhibitor IjBs via ubiquitination-dependent proteolysis and allows liberated NF-jB dimers to enter the nucleus to exert their effects [20] . IjBs phosphorylation depends mainly on the IkappaB kinase beta (IKKb) catalytic subunit of the IKK complex [21, 22] .
Here, we found that miR-429 expression was significantly decreased in CC tissues compared to corresponding paired adjacent nontumor cervical tissues, and downregulation of miR-429 promoted cell viability and proliferation while inhibiting cell apoptosis. Furthermore, miR-429 directly targeted the 3 0 UTR of IKKb and downregulated its expression. Thus, downregulation of miR-429 augmented IKKb to promote NF-jB activity and therefore promote malignancy in CC cells. Our findings provide new insights into the roles of miRNAs and the NF-jB pathway in tumorigenesis and indicate that miR-429 may serve as a potential biomarker in human CC.
Materials and methods

Cervical cancer cell lines and tumor tissues
The CC cell lines HeLa and C33A were used in this study. HeLa cells were cultured at 37°C with 5% CO 2 in RPMI 1640 media (Gibco, Gaithersburg, MD, USA) supplemented with 10% fetal bovine serum (FBS), 100 UÁmL À1 penicillin, and 100 mgÁmL À1 streptomycin. In addition, C33A cells were cultured at 37°C with 5% CO 2 in MEMa media (Gibco) supplemented with 10% fetal bovine serum, 100 UÁmL À1 penicillin, and 100 mgÁmL À1 streptomycin. Fifteen pairs of CC tissues and their matched adjacent normal tissues were collected from the Cancer Center of Sun Yat-Sen University. Informed consent was obtained from each patient, and all of the experiments were approved by the ethics committee of the institute.
Transfection
According to the manufacturer's protocol, we performed transient transfection of both HeLa and C33A cells using 
RNA preparation and quantitative reverse transcription PCR (RT-qPCR)
Total RNAs from the HeLa and C33A cell lines were extracted using the TRIZOL reagent (Invitrogen). RNAs from clinical tissue samples were extracted using the mirVana miRNA Isolation Kit (Ambion, Austin, TX, USA) according to the manufacturer's instructions. Reverse transcription quantitative PCR (RT-qPCR) was performed to detect the expression levels of genes and miRNAs. The oligo-dT primer or small RNA-specific stem-loop reverse transcription (RT) primers were used to perform reverse transcription. Quantitative PCR was performed by using SYBR Premix Ex Taq TM (TaKaRa, Dalian, China) according to the manufacturer's protocol. The housekeeping genes b-actin and U6 snRNA were used as endogenous controls for the mRNA and miRNA experiments, respectively. All the primers for RT-qPCR are listed in Table 1 .
EGFP reporter assay
The EGFP reporter assay was performed to verify the direct binding of miR-429 and IKKb. We cotransfected HeLa and C33A cells with wild-type or mutant reporter plasmid and pri-miR-429 or ASO-miR-429 separately as well as their respective controls in 48-well plates. The plasmid pDsRed2-N1, which expresses red fluorescent protein (RFP), was also cotransfected as a loading control. At 48 h post-transfection, RIPA lysis buffer (0.15 M NaCl, 0.05 M Tris/HCl pH 7.2, 1% Triton X-100, 0.1% SDS) was used to extract proteins from whole-cell lysates, and a F4500 fluorescence spectrophotometer (Hitachi, Tokyo, Japan) was used to detect the fluorescence intensities of GFP and RFP.
Western blotting
At 48 h post-transfection, we collected and lysed the cells prior to protein extraction for the detection of IKKb, NFjB, and IL-6 expression levels using western blotting. Equal amounts of protein were loaded onto 12% (for IKKb and IL-6) and 10% (for NF-jB) SDS/PAGE gels and transferred to nitrocellulose membranes. Subsequently, the membranes were incubated with 5% blotto at room temperature for 120 min. The primary antibodies, which included rabbit anti-IKKb (1 : 500), rabbit anti-NF-jB (1 : 500), rabbit anti-IL-6 (1 : 1000), and rabbit anti-IFN-b (1 : 500; Tianjin Saier Biotech, Tianjin, China), were incubated with the membrane overnight at 4°C. After three washes, the membrane was incubated with peroxidase (HRP)-conjugated anti-rabbit secondary antibody at room temperature for 120 min. The protein expression was assessed by enhanced chemiluminescence (Fujifilm, Tokyo, Japan). GAPDH and CENP-A were used as endogenous controls. LabWorks image acquisition and analysis software (UVP) was used to quantify the band intensities.
MTT assay
Cell viability was evaluated using MTT assays. 
Colony formation assay
We counted and seeded HeLa and C33A cells into 12-well plates at 300 cellsÁwell À1 at 24 h after transfection and then replaced medium with fresh culture medium every 3 days. The plates were cultured at 37°C with 5% CO 2 in a humidified incubator. After 15 days of culture, the cells were stained with crystal violet, and the rate of colony formation was calculated as previously described [5] .
Apoptosis assay by flow cytometry
We performed an apoptosis assay on C33A cells at 24 h after transfection using the Annexin V kit following the manufacturer's protocol (Sungene, Tianjin, China). In this assay, cells only positive for Annexin V represent early apoptotic populations, while those positive for both Annexin V and propidium iodide (PI) represent the late apoptotic populations, respectively, whereas cells positive for PI only represent the necrotic population. The samples Table 1 . The primers and oligonucleotides used in this work.
were analyzed with a FACS Calibur flow cytometer (BD Biosciences, SanJose, CA, USA) and FLOWJO software (version 7.6.1, https://www.flowjo.com/). We calculated the relative apoptotic rate using both early and late apoptotic cells.
ELISA assay
The IL-6 expression in culture supernatant was determined by the human IL-6 ELISA detection kit (Bocan Biotech, Shanghai, China). At 48 h post-transfection, supernatants were collected from HeLa and C33A cells and the IL-6 expressions were detected following the manufacturer's recommendation.
Statistical analysis
Data are presented as the mean AE SD. Student's t-test was performed to evaluate significant differences between control and treatment groups. P < 0.05 was considered statistically significant.
Results
miR-429 is downregulated and suppresses cell viability and proliferation while promoting apoptosis in CC cells
To determine the expression level of miR-429 in CC, 15 pairs of CC specimens were used to examine the miR-429 level by RT-qPCR. As shown in Fig. 1A , the expression of miR-429 was decreased in cancer tissues compared to adjacent normal tissues. To investigate the impact of miR-429 on the growth of CC cells, we first constructed and evaluated the efficiencies of the miR-429 overexpression vector (pri-miR-429) and miR-429 antisense oligonucleotides (ASO-miR-429) in both HeLa and C33A cells by RT-qPCR. As expected, after transfection of pri-miR-429 or ASO-miR-429, we observed a significant increase or decrease, respectively, in the miR-429 level (Fig. 1B) . Then, we performed a phenotyping assay involving gain-and loss-of-function experiments. MTT assays showed that cell viability was significantly reduced upon pri-miR-429 treatment in both HeLa and C33A cells at different time points, while ASO-miR-429 treatment significantly increased cell viability approximately 1.4-fold in HeLa cells and approximately 1.25-fold in C33A cells (Fig. 1C) . To further evaluate the long-term effects of miR-429 on growth, we performed colony formation assays after modulating miR-429 expression. Compared with the respective controls, colony formation was significantly decreased by approximately 40% and 30% upon pri-miR-429 treatment in HeLa cells and C33A cells, respectively, and increased by approximately 1.45-fold and 1.75-fold upon ASO-miR-429 treatment in HeLa cells and C33A cells, respectively (Fig. 1D) . Flow cytometry analyses indicated that overexpression of miR-429 increased apoptosis by approximately 1.6-fold, while ASO-miR-429 suppressed apoptosis by approximately 50% in C33A cells (Fig. 1D) . These data suggest that miR-429 may function as a tumor suppressor by suppressing cell growth and promoting apoptosis in human CC cells.
miR-429 targets IKKb and suppresses its expression
To further understand the molecular mechanisms of miR-429 in CC cells, we performed bioinformatics analysis using the TargetScan, PicTar, and miRBase programs to predict the potential targets of miR-429. Among these potential targets, IKKb was chosen as a candidate target gene because it promotes cell growth [23] .
To determine the effect of miR-429 on the expression of IKKb, RT-qPCR and western blot analysis were applied to examine the mRNA and protein levels of IKKb after alterations of miR-429 in both HeLa and C33A cells. We observed that the IKKb mRNA levels were significantly decreased by approximately 60 and 70% in miR-429-treated HeLa and C33A cells, respectively, compared with the empty vector controls, while ASO-miR-429 augmented the IKKb mRNA levels by approximately 3.2-fold and 2.7-fold in HeLa and C33A cells ( Fig. 2A) . In agreement with the RTqPCR results, overexpression of miR-429 reduced IKKb protein expression, while blocking of miR-429 increased IKKb protein expression (Fig. 2B) .
Using bioinformatics analysis, we identified a potential miR-429-binding site in the 3 0 UTR (position: 901-907 nucleotides) of IKKb. We constructed EGFP fluorescence reporter vectors that contained wild-type and mutant (five nucleotides were mutated in the seed sequence-binding region) forms of the IKKb 3 0 UTR downstream of EGFP (Fig. 2C) . EGFP reporter assays revealed that miR-429 reduced the expression of EGFP by approximately 20 and 30% compared with the control groups in HeLa cells and C33A cells, respectively, while the fluorescence intensity of the mutant form did not change in either HeLa cells or C33A cells (Fig. 2D) . On the contrary, the EGFP expression in the ASO-miR-429 cotransfected cells was enhanced by approximately 1.2-and 1.3-fold in HeLa cells and C33A cells, respectively (Fig. 2D) . Similarly, no significant changes in EGFP expression were observed in the cells cotransfected with the mutant form (Fig. 2D) . These data provide evidence that miR-429 directly binds to the 3 0 UTR of IKKb and specifically suppresses the expression of IKKb.
To explore the correlation between miR-429 and IKKb in human CC tissues, we examined IKKb expression levels in 15 pairs of clinical CC samples by RTqPCR. The results showed that IKKb was expressed at a higher level in CC tissues compared to adjacent normal tissues (Fig. 2E) . The correlation analysis showed that the expression levels of miR-429 and IKKb were negatively correlated in CC tissues (r = À0.51, P < 0.05). These results suggest that the expression of miR-429 was inversely correlated with IKKb expression. Colony formation assays revealed the relative average colony formation rates. The colony formation rate was calculated using the following formula: colony formation rate = (number of colonies formed/number of plated cells) 9 100%. (E) Cell apoptosis was determined by flow cytometry analysis of Annexin V-FITC/PI staining in C33A cells at 24 h post-transfection. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. The negative association between miR-429 and IKKb expression was assessed by Pearson's correlation analysis in 15 paired cervical tissues (r = À0.51, P < 0.05). *P < 0.05, **P < 0.01, ns = not significant.
IKKb promotes cell viability and proliferation while inhibiting cell apoptosis
To further investigate the effects of IKKb on cell proliferation and apoptosis in CC cells, we constructed an IKKb expression vector (pcDNA3/IKKb without the 3 0 UTR) and an IKKb silencing vector (pSilencer/shRIKKb) and performed gain-and loss-of-function experiments. The efficiencies of the vectors were verified by RT-qPCR and western blot analysis in both HeLa and C33A cells (Fig. 3A,B) . Subsequently, we performed MTT assays, colony formation assays, and apoptosis analysis via flow cytometry after modulating IKKb expression. Overexpression of IKKb increased cell viability by approximately 1.25-fold (Fig. 3C) and increased the Flow cytometry analysis revealed a decrease in the cell apoptosis rate with the overexpression of IKKb in C33A cells. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. colony formation rate by approximately 1.25-fold (Fig. 3D ) compared with the empty vector controls, whereas silencing the endogenous expression of IKKb decreased cell viability by approximately 20 and 25% (Fig. 3C) and reduced colony formation rates approximately 25 and 30% in both HeLa and C33A cells (Fig. 3D) . The flow cytometry assays showed that knockdown of IKKb increased cell apoptosis by approximately 1.7-fold, but overexpression of IKKb reduced cell apoptosis by approximately 60% in C33A cells (Fig. 3E) . These data suggest that IKKb has an oncogenic role in human CC cells.
Ectopic expression of IKKb rescues the defects caused by miR-429 in CC cells
To further confirm that the effects of miR-429 on cell proliferation and apoptosis in CC cells are mediated by IKKb, we performed rescue experiments. Ectopic expression of IKKb rescued the defects caused by miR-429 in HeLa and C33A cells (Fig. 4A) . Briefly, as shown in Fig. 4B ,C, ectopic expression of IKKb abolished the suppressive effects of miR-429 on cell viability and colony formation. The flow cytometry assay also demonstrated that IKKb overexpression counteracted the miR-429-induced promotion of apoptosis in , colony formation assays (C) and flow cytometry analysis (D). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
C33A cells (Fig. 4D) . These results demonstrated that IKKb mediates the effects of miR-429 on cell proliferation and apoptosis in CC cells.
miR-429 reduces the expression of IL-6 and IFN-b in IKKb/NF-jB-dependent manner IKKb/NF-jB is a classic signaling pathway that plays an important role in tumorigenesis [22] . To investigate whether miR-429 influences the activity of the NF-jB signaling pathway, we examined the expression of activated-NF-jB target genes, IL-6, and IFN-b. Western blotting assay showed that IL-6 expression was decreased in pri-miR-429-transfected CC cells and increased in ASO-miR-429 transfected CC cells (Fig. 5A) , and the similar results were observed in supernatant from CC cells by ELISA assay (Fig. 5B) . Given that the activation of NF-jB participated in the induction of IFN-b, we also detected the expression level of IFN-b by western blotting, as shown in Fig. 5C ; overexpression of pri-miR-429 reduced IFN-b protein level, while blocking miR-429 increased IFN-b protein level. In addition, ectopic expression of IKKb counteracted the miR-429-induced suppression of NF-jB pathway activation (Fig. 5D,E) . Altogether, these results indicate that miR-429 downregulates NFjB signaling pathway through repressing IKKb.
Discussion
miRNAs regulate the expression of their target genes by binding to complementary sites in the 3 0 UTRs of mRNA sequences to inhibit mRNA translation or induce mRNA degradation [24] . It was found that miRNAs are involved in the initiation and progression of malignancies, with roles in cell proliferation, apoptosis, invasion, and metastasis, and miRNAs may function as either tumorigenic or tumor-suppressing genes in tumor tissue [25] . For example, in CC cells, it was found that miR-181 exhibited a tumorigenic role by repressing the expression of adenylyl cyclase 9 (AC9) to promote cell proliferation and decrease apoptosis [3] ; however, it was also found that miR-214 reduced cell survival and enhanced cisplatin-induced cytotoxicity via downregulation of Bcl2 l2 in CC cells [26] . Understanding the role of miRNAs that are aberrantly expressed in CC can help us to understand the underlying mechanisms of CC and improve therapeutic approaches for CC. In this study, we found that miR-429 was downregulated in CC tissues compared to normal adjacent tissues, which suggests that miR-429 may play an important role in cervical carcinogenesis.
Our subsequent experiments showed that miR-429 inhibited cell proliferation and colony formation while increasing cell apoptosis in HeLa and C33A cells. Previous studies have shown that miR-429 exhibited various functions in different tumors. miR-429 was found to play an oncogenic role in endometrial carcinoma [27] , ovarian carcinoma [28] , and colorectal cancer [29] . However, miR-429 was also found to have a tumor-suppressive role; for example, miR-429 was found to reduce the expression of ZEB1 and therefore weaken oral squamous cell carcinoma growth [30] . miR-429 was also found to suppress the migration and invasion of breast cancer cells by downregulating the expression of ZEB1 and CRKL proteins [31] . These results are consistent with our results in CC. Next, we identified IKKb as a new target of miR-429 using an EGFP reporter assay as well as gain-and loss-of-function experiments. IKKb, one of the catalytic subunits of the IKK complex, can phosphorylate IKBs, which are inhibitors of NF-jB. Subsequently, NF-jB can translocate to the nucleus to regulate a variety of target genes [22] . A large number of studies have shown that IKKb is associated with the occurrence of a variety of tumors. For example, miR-199a attenuates endometrial stromal invasiveness through suppression of IKKb/NF-jB [32] . In addition, the IKKb/NF-ΚB pathway is sufficient to drive the development and growth of angiosarcoma [33] . In our study, we demonstrated that IKKb promotes oncogenic activity and may mediate the effects of miR-429 on malignancy, as evidenced by a rescue experiment in CC cells.
From the observations we obtained from this study, we speculate that miR-429 may influence the activation of the IKKb/NF-jB pathway. We revealed that during activation of the NF-jB pathway, miR-429 reduced the level of activated-NF-jB by suppressing IKKb. Activation of the NF-jB pathway is followed by the upregulation of IL-6 [34, 35] and NF-kB functions as transcription factors positively regulate the expression of downstream target gene IFN-b [36] . To further investigate the influence of miR-429 on activation of the NFjB, we detected the expression level of IL-6 and IFN-b in CC cells and found that miR-429 decreased their induction in the IKKb/NF-jB pathway.
In conclusion, our results indicate that downregulation of miR-429 attenuates the suppression of IKKb, which facilitates activation of the NF-jB pathway to contribute to malignancy in CC cells. This finding suggests that miR-429 may function as a tumor suppressor in CC. Our work provides new insight into the crosstalk between miRNAs and the NF-jB pathway during tumorigenesis and highlights miR-429 as a potential biomarker of CC.
